All companies
Visit website
VIRONIX HEALTH INC.
OperatingVironix Health Inc.
Healthcare · Founded 2020
AI-enabled early detection and remote monitoring of lung and heart disease
Post-money valuation ⓘ
$11.2M
As of Apr 2023 · from VIRONIX HEALTH INC. Preferred Stock 1 · pre-money + amount raised, not a traded price
Total raised
$0
Across 1 round since 2022
Latest share price
$10.66
VIRONIX HEALTH INC. Preferred Stock 1 offering price
Financials
FY2020–FY2024 · from SEC filings · hover any figure for its source$0
−$25K
2020
$2K
−$141K
2021
$2K
−$141K
2022
$57
−$302K
2023
$2K
−$792K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$0
$2,408
$2,408
$57
$2,325
Cost of goods sold
$0
$0
$0
$0
$0
Gross margin
—
100%
100%
100%
100%
Net income
-$24,539
-$141,223
-$141,223
-$302,311
-$792,139
Taxes paid
$0
$0
$0
$0
$1,181
Balance sheet
Cash
$208,912
$103,621
$103,621
$709,378
$842,883
Accounts receivable
$0
$0
$0
$0
$0
Total assets
$224,843
$234,886
$234,886
$1,190,951
$1,424,170
Short-term debt
$23,370
$10,910
$10,910
$31,476
$37,841
Long-term debt
$226,000
$289,726
$289,726
$0
$0
Total liabilities
$249,370
$300,636
$300,636
$31,476
$37,841
Other
Headcount
—
3
—
6
6
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$11.2M
post-money
VIRONIX HEALTH INC. Preferred Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised — / $1.1MPost-money $11.2M
Reg CF annual-report compliance
Not obligated
never closed a Reg CF raise
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 18 filings on EDGARSource: ManualCIK 0001833036Share price $10.66
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.